Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study was to evaluate the efficacy and safety of bivalirudin in anticoagulation therapy in patients with extracorporeal membrane oxygenation (ECMO) compared with unfractionated heparin.
Epistemonikos ID: dc93239aa6cd3b9475b652a712e9721dd70b9149
First added on: May 15, 2024